Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

机译：贝伐单抗在土耳其转移和复发性宫颈癌患者中的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer.

机译：评价Bevacizumab一种单克隆，抗病毒内皮生长因子抗体与土耳其患者复发性和转移性宫颈癌的细胞毒性化疗组合的疗效。

著录项

期刊名称 Turkish Journal of Obstetrics and Gynecology
作者
Özlem Ercelep; Deniz Tataroğlu; Melike Özçelik; Heves Sürmeli; Mustafa Değirmenci; Mevlüde İnanç; Mehmet Aliustaoğlu; Mahmut Gümüş;
展开▼
作者单位

展开▼
年(卷),期 2020(17),2
年度 2020
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类妇产科学;
关键词
Cervical cancer; bevacizumab; metastatic;

相似文献

外文文献
中文文献
专利

1. The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer [J] . Minion Lindsey E., Tewari Krishnansu S. Expert review of anticancer therapy . 2017,第1a6期

机译：Bevacizumab在患有复发性或转移性宫颈癌患者治疗中的安全性和疗效
2. Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials [J] . Xiaoqun Liu, Xiangdong Liu, Tiankui Qiao, OncoTargets and therapy . 2016,第6期

机译：贝伐单抗/紫杉烷方案中添加药物对局部复发或转移性乳腺癌Her2阴性患者的一线治疗的有效性和安全性：七项随机对照试验的结果
3. Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study [J] . XU Bing-he, TONG Zhong-sheng, QIN Shu-kui, 中华医学杂志（英文版） . 2012,第005期

机译：一线贝伐单抗联合紫杉烷治疗在中国HER2阴性局部复发或转移性乳腺癌患者中的安全性和有效性：ATHENA研究发现
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials [O] . Xiaoqun Liu, Xiangdong Liu, Tiankui Qiao, 2016

机译：贝伐单抗/紫杉烷方案中添加药物对局部复发或转移性乳腺癌Her2阴性患者的一线治疗的有效性和安全性：七项随机对照试验的结果
7. Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials [O] . Xiao-Qun Liu, Xiangdong Liu, Tiankui Qiao, 2016

机译：将药剂添加到Bevacizumab /紫杉烷方案中的疗效和安全性用于局部复发或转移性乳腺癌的一线治疗Her2阴性患者的一线治疗：来自七项随机对照试验的结果

Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅